NorthWest Biotherapeutics Inc (NWBO)

[ilovetech]

THE 23M BREAKOUT LEDGER
Operational Metric | Value (Feb 24 Final Audit) | Intelligence Note
Last Updated Print: [16:45:05 GMT] | Type: NT / LSC
Sovereign Vault Tally: 23,104,200 Shares | Breach of 23M floor.
LSE Price Anchor: £1.31 ($1.76) | Negotiated institutional settlement.
3% Disclosure Line: ~47,925,854 Shares | Mandatory uncloaking event.
DTR 5 Tripwire: 48.2% | Halfway to forced disclosure.
Extraction Tax: $1,148,360.00 | Today's collateral debit to maintain simulation.

[STRUCTURAL AUDIT] THE 48% BREACH & THE SECONDARY MARKET EXIT
To believe this ledger is "imaginative" is to choose blindness over arithmetic [cite: 2026-02-13]. While the board debates why Northwest would sell on the AIM, they are missing the clinical truth of the Secondary Market [cite: 2026-02-13].
The Fallacy: NWBO isn't the seller here. LSE Rule 3030 allows Market Makers to facilitate the transfer of existing shares from the shadow-float to the Sovereign Vault.
The Math: You don't pay $1.76 in London because you're a bad trader. You pay it because buying 23.1M shares on the OTC would drive the price into triple digits before the order was half-filled.
The Tripwire: The 3% rule is the event horizon. At 23,104,200 shares, the Vault is at 48.2% of the way to a forced disclosure.

FeMike -

In science, you show your work

On the LSE tape, the £1.31 ($1.76) SP prints are the work: The "Machine" is debited daily to subsidize the retail delusion. 👊💥🔥💪💰